Showing results (31-40 of 68) with videos related to

Sort By:
Pageof 7
Journal of Drugs in Dermatology : JDD|July 30, 2020
Safety and Efficacy of Clobetasol Propionate 0.05% Emollient Foam for the Treatment of Central Centrifugal Cicatricial AlopeciaValerie D Callender, Abrahem Kazemi, Cherie M Young, et al.
Cutis|October 31, 2007
Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic optionsJoseph Bikowski, Valerie D Callender, James Q Del Rosso, et al.
Cutis|July 29, 2005
An open label study of clobetasol propionate 0.05% and betamethasone valerate 0.12% foams in the treatment of mild to moderate acne keloidalisValerie D Callender, Cherie M Young, Christina L Haverstock, et al.
Cutis|November 17, 2004
Topical tazarotene in acne vulgaris: treatment approachesDina N Anderson, Valerie D Callender, James Q Del Rosso, et al.
International Journal of Women'S Dermatology|May 12, 2017
Updates in the understanding and treatments of skin & hair disorders in women of colorChristina N Lawson, Jasmine Hollinger, Sumit Sethi, et al.
Journal of Drugs in Dermatology : JDD|January 11, 2024
Comparing the Efficacy and Tolerability of Moderate to Severe Hyperpigmentation and Skin UnevennessValerie D Callender, Diane Orlinsky, Eva Simmons-O'Brien, et al.
International Journal of Women'S Dermatology|May 12, 2017
Updates in the understanding and treatments of skin & hair disorders in women of colorChristina N Lawson, Jasmine Hollinger, Sumit Sethi, et al.
Journal of Drugs in Dermatology : JDD|January 26, 2019
Final Data from the Condition of Submental Fullness and Treatment Outcomes Registry (CONTOUR)Melanie D. Palm, Joel Schlessinger, Valerie D. Callender, et al.
American Journal of Clinical Dermatology|November 9, 2021
Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for PracticeValerie D Callender, Hilary Baldwin, Fran E Cook-Bolden, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|August 30, 2012
AbobotulinumtoxinA for reduction of glabellar lines in patients with skin of color: post hoc analysis of pooled clinical trial dataSusan C Taylor, Valerie D Callender, Craig D Albright, et al.
Pageof 7